camptothecin has been researched along with lamellarin d in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bailly, C; Gago, F; Ishibashi, F; Iwao, M; Laine, W; Lansiaux, A; Marco, E; Tardy, C | 1 |
| Baldeyrou, B; Bourg, S; Buron, F; Lansiaux, A; Lozach, O; Meijer, L; Mérour, JY; Neagoie, C; Rosca, S; Routier, S; Vedrenne, E | 1 |
| Durieu, E; Fukuda, T; Ishibashi, F; Itoyama, R; Iwao, M; Loaëc, N; Lozach, O; Meijer, L; Tanaka, J; Yamahira, M; Yoshida, K | 1 |
| Fujimoto, M; Fukuda, T; Ishibashi, F; Iwao, M; Nanjo, Y; Natsui, Y; Okazaki, F; To, H; Yoshida, K | 1 |
| Goon, S; Kundu, B; Mondal, MA; Sarkar, D; Talukdar, A | 1 |
| Bailly, C; Beauvillain, JC; Cuevas, C; Gallego, MA; Kluza, J; Loyens, A; Marchetti, P; Sousa-Faro, JM | 1 |
| Agama, K; Lorence, N; Neuman, KC; Pommier, Y; Seol, Y; Zhang, H | 1 |
| Collin, S; Criscuolo, A; Dahmane, N; Delmas, S; Desnoues, N; Eberhard, S; Forterre, P; Gadelle, D; Pommier, Y; Sezonov, G; Zhang, H | 1 |
1 review(s) available for camptothecin and lamellarin d
| Article | Year |
|---|---|
Topoisomerase I inhibitors: Challenges, progress and the road ahead.
Topics: Antineoplastic Agents; Camptothecin; DNA Topoisomerases, Type I; Irinotecan; Poisons; Topoisomerase I Inhibitors | 2022 |
7 other study(ies) available for camptothecin and lamellarin d
| Article | Year |
|---|---|
Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Computer Simulation; Coumarins; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Heterocyclic Compounds, 4 or More Rings; Humans; Intercalating Agents; Isoquinolines; Models, Molecular; Protein Binding; Structure-Activity Relationship; Thermodynamics; Topoisomerase I Inhibitors | 2005 |
Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.
Topics: Coumarins; DNA Topoisomerases, Type I; Dyrk Kinases; Heterocyclic Compounds, 4 or More Rings; Humans; Indoles; Isoquinolines; Models, Molecular; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2012 |
Synthesis, resolution, and biological evaluation of atropisomeric (aR)- and (aS)-16-methyllamellarins N: unique effects of the axial chirality on the selectivity of protein kinases inhibition.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; DNA Topoisomerases, Type I; Humans; Molecular Docking Simulation; Polycyclic Compounds; Protein Conformation; Protein Kinase Inhibitors; Protein Kinases; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity; Topoisomerase I Inhibitors | 2013 |
Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffold.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Coumarins; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Male; Mice, Inbred BALB C; Molecular Structure; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2019 |
Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Membrane Permeability; Cell-Free System; Coumarins; Cytochromes c; Heterocyclic Compounds, 4 or More Rings; Humans; Isoquinolines; Leukemia P388; Lung Neoplasms; Membrane Potentials; Mice; Mitochondria; Mitochondrial Membranes; NIH 3T3 Cells; Rats | 2006 |
Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.
Topics: Antineoplastic Agents; Benzodioxoles; Camptothecin; Cell Line, Tumor; Cell Proliferation; Coumarins; DNA Cleavage; DNA Topoisomerases, Type I; DNA, Superhelical; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Isoquinolines; Kinetics; Molecular Structure; Nucleic Acid Conformation; Substrate Specificity; Topoisomerase I Inhibitors | 2015 |
topIb, a phylogenetic hallmark gene of Thaumarchaeota encodes a functional eukaryote-like topoisomerase IB.
Topics: Amino Acid Sequence; Archaea; Archaeal Proteins; Camptothecin; Cloning, Molecular; Coumarins; DNA Topoisomerases, Type I; DNA, Superhelical; Escherichia coli; Gene Expression; Heterocyclic Compounds, 4 or More Rings; Hot Temperature; Humans; Isoquinolines; Mitochondrial Proteins; Models, Molecular; Molecular Sequence Data; Phylogeny; Protein Stability; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins; Sequence Alignment; Topoisomerase I Inhibitors | 2016 |